CORONA
Start SIP
Invest Now
Start SIP in CORONA
Corona Remedies live price: ₹1588.6. It opened at ₹1,610 vs previous close ₹1,617; intraday high/low: ₹1,622/₹1,582. The 50 DMA stands at ₹1,512.22.
Corona Remedies Performance
- Low
- ₹1,582
- High
- ₹1,622
- 52 Week Low
- ₹1,337
- 52 Week High
- ₹1,699
- Open Price₹1,610
- Previous Close₹1,617
- Volume7,599
- 50 DMA₹1,512.22
- 100 DMA-
- 200 DMA-
Investment Returns
- Over 1 Month -1.13%
- Over 3 Month + 49.59%
- Over 6 Month + 49.59%
- Over 1 Year + 49.59%
Smart Investing Starts Here Start SIP with Corona Remedies for Steady Growth!
Corona Remedies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -
- PEG Ratio
- -
- Market Cap Cr
- 9,716
- P/B Ratio
- 13.9
- Average True Range
- 60.13
- EPS
- 30.17
- Dividend Yield
- 0
- MACD Signal
- 26.22
- RSI
- 53.41
- MFI
- 75.51
Corona Remedies Financials
Corona Remedies Technicals
EMA & SMA
Current Price
₹1,588.60
-27.9
(-1.73%)
- Bearish Moving Average 3
- Bullish Moving Average 8
- 20 Day
- ₹1,575.94
- 50 Day
- ₹1,512.22
- 100 Day
- -
- 200 Day
- -
Resistance and Support
1597.57
- R3 1,652.33
- R2 1,637.07
- R1 1,612.83
- S1 1,573.33
- S2 1,558.07
- S3 1,533.83
Corona Remedies Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-02 | Quarterly Results | |
| 2026-01-02 | Quarterly Results | Inter-alia, to consider and approve the financial results for the period ended September 30, 2025 |
Corona Remedies F&O
About Corona Remedies
- NSE Symbol
- CORONA
- BSE Symbol
- 544644
- Managing Director & CEO
- Mr. Niravkumar Kirtikumar Mehta
- ISIN
- INE02ZQ01018
Similar Stocks to Corona Remedies
Corona Remedies FAQs
Corona Remedies share price is ₹1,588 As on 13 March, 2026 | 02:06
The Market Cap of Corona Remedies is ₹9715.9 Cr As on 13 March, 2026 | 02:06
The P/E ratio of Corona Remedies is As on 13 March, 2026 | 02:06
The PB ratio of Corona Remedies is 13.9 As on 13 March, 2026 | 02:06
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.